19 Nov 2020

BioPorto Diagnostics - COVID-19 test to enter the clinic

- Dr Nathaniel Calloway
- 6 pages

With its Q320 earnings, BioPorto announced that its COVID-19 antigen test it has under development would be entering the clinic. The gathering of samples is expected to start imminently and to be complete by the end of December 2020. The company believes that this timeline supports the potential commercialisation of the product in early 2021, if the results of the study are compelling.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

BioPorto Diagnostics - COVID-19 test to enter the clinic

BioPorto A/S (BIOPOR:CSE) | 0 0 0.0%

Published: 19 Nov 2020
Author: Dr Nathaniel Calloway
Pages: 6

With its Q320 earnings, BioPorto announced that its COVID-19 antigen test it has under development would be entering the clinic. The gathering of samples is expected to start imminently and to be complete by the end of December 2020. The company believes that this timeline supports the potential commercialisation of the product in early 2021, if the results of the study are compelling.